Pincer Biotech ApS: Financial statements 2022
CVR: 40497978
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pincer Biotech ApS (CVR 40497978) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -406,800 and a net result of DKK -409,324 compared with DKK -253,003 the year before. Equity in the 2022 report amounted to DKK 27,415. The solvency ratio was 1.4%.
- Gross Profit
- DKK -406,800
- Profit/Loss
- DKK -409,324
- Equity
- DKK 27,415
- Total Assets
- DKK 2,023,845
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -407K | -409K | 27K | 0 |
| 2021 | - | -222K | -253K | 437K | 0 |
| 2020 | - | -44K | -27K | 690K | 0 |
Official annual report
Keep an eye on Pincer Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pincer Biotech ApS has published its annual report for 2021. Gross profit came to DKK -221,706, and the net result was DKK -253,003.
As of May 18, 2022, Charlotte Dyring is registered as adm. dir. of Pincer Biotech ApS.
About Pincer Biotech ApS
Pincer Biotech ApS was a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2019. The company has been dissolved on 28 May 2024. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. According to the 2022 annual report, the company had an average of 0 employees. In 2022, the company reported a gross profit of DKK -406,800 and a net result of DKK -409,324 compared with DKK -253,003 the year before. Equity in the 2022 report amounted to DKK 27,415.